Moderna CEO Says Personalized Cancer Vaccine With Merck Could Work in Many Tumors

Summary

Moderna CEO Stephane Bancel said the personalized mRNA cancer vaccine that Moderna is developing with Merck should work in a variety of tumors, not only melanoma. He made the remarks in an interview with Romaine Bostick on the Bloomberg program The Close. Bancel also said the recent data leak for the cancer vaccine candidate did not come from either Moderna or Merck.

Timeline

1. Bloomberg

   26 Oct 2026, 19:59 UTCSource ↗

   Bloomberg reports that Moderna CEO Stephane Bancel believes the personalized mRNA cancer vaccine being developed with Merck will work in a variety of tumors, and that the recent data leak for the candidate did not come from either company.